VIDA is focused on changing the practice of pulmonary care by empowering the pulmonary clinician with precision informatics. VIDA's suite of software and associated analysis services aid early detection, evaluation, and treatment planning of lung diseases, including lung cancer, emphysema, airway obstructive diseases, and asthma. VIDA's software and services are cleared for clinical use in the United States, Canada, European Union, and Australia. VIDA is headquartered in Coralville, IA, with an additional office in Minneapolis, MN.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/21/16 | $5,100,000 | Series B |
Chartline Capital Partner Iowa Seed Fund Next Level Ventures Northern California Investment Fund Rittenhouse Ventures Rural Vitality Fund II | undisclosed |
| 07/25/19 | undisclosed | Strategic |
UnityPoint Health Ventures | undisclosed |
| 03/12/20 | $11,000,000 | Series C |
Blue Heron Capital Chartline Capital Partner First Analysis  Iowa First Capital Fund Next Level Ventures Rittenhouse Ventures Rural Vitality Fund II The Angels' Forum UnityPoint Health Ventures | undisclosed |
| 04/15/20 | $2,000,000 | Series C |
OSF Ventures | undisclosed |
